A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer
J. P. Micha, B. H. Goldstein, M. A. Rettenmaier, M. Genesen, C. Graham, K. Bader, K. L. Lopez, M. Nickle, J. V. Brown
International Journal of Gynecologic Cancer Jul 2007, 17 (4) 771-776; DOI: 10.1136/ijgc-00009577-200707000-00003